Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 3
2004 8
2005 6
2006 4
2007 5
2008 10
2009 10
2010 9
2011 7
2012 5
2013 4
2014 7
2015 10
2016 8
2017 5
2018 8
2019 7
2020 6
2021 9
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.
Zhou J, Zaiss M, Knutsson L, Sun PZ, Ahn SS, Aime S, Bachert P, Blakeley JO, Cai K, Chappell MA, Chen M, Gochberg DF, Goerke S, Heo HY, Jiang S, Jin T, Kim SG, Laterra J, Paech D, Pagel MD, Park JE, Reddy R, Sakata A, Sartoretti-Schefer S, Sherry AD, Smith SA, Stanisz GJ, Sundgren PC, Togao O, Vandsburger M, Wen Z, Wu Y, Zhang Y, Zhu W, Zu Z, van Zijl PCM. Zhou J, et al. Among authors: laterra j. Magn Reson Med. 2022 Aug;88(2):546-574. doi: 10.1002/mrm.29241. Epub 2022 Apr 22. Magn Reson Med. 2022. PMID: 35452155 Free PMC article. Review.
Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.
Douville C, Curtis S, Summers M, Azad TD, Rincon-Torroella J, Wang Y, Mattox A, Avigdor B, Dudley J, Materi J, Raj D, Nair S, Bhanja D, Tuohy K, Dobbyn L, Popoli M, Ptak J, Nehme N, Silliman N, Blair C, Judge K, Gallia GL, Groves M, Jackson CM, Jackson EM, Laterra J, Lim M, Mukherjee D, Weingart J, Naidoo J, Koschmann C, Smith N, Schreck KC, Pardo CA, Glantz M, Holdhoff M, Kinzler KW, Papadopoulos N, Vogelstein B, Bettegowda C. Douville C, et al. Among authors: laterra j. Cell Rep Med. 2023 Aug 15;4(8):101148. doi: 10.1016/j.xcrm.2023.101148. Epub 2023 Aug 7. Cell Rep Med. 2023. PMID: 37552989 Free PMC article.
Druggable genomic landscapes of high-grade gliomas.
Ghanem P, Fatteh M, Kamson DO, Balan A, Chang M, Tao J, Blakeley J; Johns Hopkins Molecular Tumor Board Investigators; Canzoniero J, Grossman SA, Marrone K, Schreck KC, Anagnostou V. Ghanem P, et al. Front Med (Lausanne). 2023 Dec 8;10:1254955. doi: 10.3389/fmed.2023.1254955. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38143440 Free PMC article.
Neuro-Oncology: Current Concepts and Emerging Therapeutics.
Nabors B, Laterra J. Nabors B, et al. Among authors: laterra j. Neurotherapeutics. 2017 Apr;14(2):253-255. doi: 10.1007/s13311-017-0529-8. Neurotherapeutics. 2017. PMID: 28397114 Free PMC article. No abstract available.
Extraneural Glioblastoma Multiforme Vertebral Metastasis.
Goodwin CR, Liang L, Abu-Bonsrah N, Hdeib A, Elder BD, Kosztowski T, Bettegowda C, Laterra J, Burger P, Sciubba DM. Goodwin CR, et al. Among authors: laterra j. World Neurosurg. 2016 May;89:578-582.e3. doi: 10.1016/j.wneu.2015.11.061. Epub 2015 Dec 15. World Neurosurg. 2016. PMID: 26704201 Free PMC article. Review.
ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma.
Hu C, Wang K, Damon C, Fu Y, Ma T, Kratz L, Lal B, Ying M, Xia S, Cahill DP, Jackson CM, Lim M, Laterra J, Li Y. Hu C, et al. Among authors: laterra j. Neuro Oncol. 2022 Jun 1;24(6):888-900. doi: 10.1093/neuonc/noab292. Neuro Oncol. 2022. PMID: 34951647 Free PMC article.
Investigational new drugs for brain cancer.
Staedtke V, Bai RY, Laterra J. Staedtke V, et al. Among authors: laterra j. Expert Opin Investig Drugs. 2016 Aug;25(8):937-56. doi: 10.1080/13543784.2016.1182497. Epub 2016 May 17. Expert Opin Investig Drugs. 2016. PMID: 27170161 Free PMC article. Review.
Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.
Lopez-Bertoni H, Johnson A, Rui Y, Lal B, Sall S, Malloy M, Coulter JB, Lugo-Fagundo M, Shudir S, Khela H, Caputo C, Green JJ, Laterra J. Lopez-Bertoni H, et al. Among authors: laterra j. Signal Transduct Target Ther. 2022 Feb 9;7(1):37. doi: 10.1038/s41392-021-00857-0. Signal Transduct Target Ther. 2022. PMID: 35136034 Free PMC article.
130 results